Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego.
The leading continuous glucose monitor (CGM) maker filed a Worker Adjustment and Retraining Notification (WARN) notice in California on Aug. 27. California officials processed the filing on Aug. 28 and the headcount cut goes into effect on Nov. 3, 2025.
(MassDevice has tracked industry layoffs over the past couple of years — see who reduced their workforces here.)
According to the WARN database, the “permanent layoff” affects a total of 319 employees. It takes place at Dexcom’s facility at 6290-6350 Sequence Drive in San Diego.
Dexcom’s most recent annual report, filed in February, lists approximately 10,300 employees around the globe. The elimination of 319 roles would represent approximately 3.1% of the company’s global workforce.
Read more about Dexcom and the rest of the diabetes tech industry in our free Diabetes Technology Special Report.
Dexcom — one of the largest diabetes tech companies in the world — last year announced plans to relocate its manufacturing operations. This shift included plans to eliminate more than 500 positions in San Diego as manufacturing moved to Mesa, Arizona.
The company’s headquarters remain in San Diego. However, its decision to move manufacturing to Arizona signals that Dexcom outgrew its facilities in San Diego. In total, that shift cut 536 manufacturing employees from Dexcom’s San Diego operations, equaling about 15% of the company’s U.S. manufacturing headcount. The company expected to recoup close to the amount of employees that it cut at its headquarters.
It remains unclear if this WARN filing is related to the manufacturing move or if it is a separate headcount reduction.
According to the WARN letter issued by Dexcom, shared with Drug Delivery Business News by the California Employment Development Dept. (EDD), the layoffs affected a wide range of positions. The positions most affected included varying levels of manufacturing associates (82 employees across four levels of associate), associate district account representatives (29 employees) and three levels of material handlers (19 employees).
The letter notes that the action is expected to be permanent. Employees affected are not represented by a union. Bumping rights do not exist for the affected positions.
Drug Delivery Business News has reached out to Dexcom for more information. This article may be updated.
